You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Undifferentiated Pleomorphic Sarcoma

Showing 1 - 25 of 1,289
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

Not yet recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Nov 1, 2023

Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

Recruiting
  • Locally Advanced Undifferentiated Pleomorphic Sarcoma
  • +3 more
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound

Recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

Active, not recruiting
  • Dedifferentiated Liposarcoma
  • +5 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Sarcoma, Soft Tissue Trial in Beijing (Recombinant anti-PD-1 humanized mAb injection)

Not yet recruiting
  • Sarcoma, Soft Tissue
  • Recombinant anti-PD-1 humanized monoclonal antibody injection
  • Beijing, Beijing, China
    Beijing Jishuitan Hospital
Dec 31, 2021

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Sarcoma Trial in London (Pembrolizumab, Gemcitabine)

Active, not recruiting
  • Sarcoma
  • London, United Kingdom
    Royal Marsden
Jun 29, 2021

Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • +6 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

    Recruiting
    • Sarcoma
    • +3 more
    • Isolated Limb Infusion
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Nov 21, 2022

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

    Recruiting
    • Bone Sarcoma
    • +6 more
    • Treatment by Regorafenib
    • Treatment by Placebo
    • Besançon, France
    • +15 more
    Aug 18, 2022

    Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

    Withdrawn
    • Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Jul 26, 2021

    Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)

    Terminated
    Has Results
    • Solid Tumor
    • +8 more
    • Houston, Texas
    • +1 more
    Aug 4, 2021

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021

    Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

    Active, not recruiting
    • Sarcoma
    • +10 more
    • Hypofractionated radiotherapy
    • Hyperthermia
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 27, 2021

    Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

    Completed
    Has Results
    • Adult Alveolar Soft Part Sarcoma
    • +18 more
    • Portland, Oregon
    • +1 more
    Sep 23, 2021

    Sarcoma Trial (Camrelizumab and Apatinib)

    Unknown status
    • Sarcoma
    • Camrelizumab and Apatinib
    • (no location specified)
    Jun 23, 2020

    Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)

    Recruiting
    • Sarcoma, Soft Tissue
    • Shanghai, Shanghai, China
      Fudan University, Cancer Hospital
    Jul 13, 2020

    Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

    Recruiting
    • Melanoma (Excluding Uveal Melanoma)
    • +15 more
    • XmAb®23104
    • Yervoy® (ipilimumab)
    • San Diego, California
    • +15 more
    Sep 20, 2021